Introduction to Mammalian Genome special issue: inflammation and immunity in cancer.
- Published in:
- Mammalian Genome, 2018, v. 29, n. 11/12, p. 691, doi. 10.1007/s00335-018-9787-y
- By:
- Publication type:
- Article
Works matching IS 09388990 AND DT 2018 AND VI 29 AND IP 11/12
Results: 16
1
2
Perspective: cancer vaccines in the era of immune checkpoint blockade.
- Published in:
- Mammalian Genome, 2018, v. 29, n. 11/12, p. 703, doi. 10.1007/s00335-018-9786-z
- By:
- Publication type:
- Article
3
Correction to: The role of proteomics in the age of immunotherapies.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
4
NLRP3 inflammasome in colitis and colitis-associated colorectal cancer.
- Published in:
- Mammalian Genome, 2018, v. 29, n. 11/12, p. 817, doi. 10.1007/s00335-018-9783-2
- By:
- Publication type:
- Article
5
Lessons learnt from the Tasmanian devil facial tumour regarding immune function in cancer.
- Published in:
- Mammalian Genome, 2018, v. 29, n. 11/12, p. 731, doi. 10.1007/s00335-018-9782-3
- By:
- Publication type:
- Article
6
Roles of cytotoxic and helper innate lymphoid cells in cancer.
- Published in:
- Mammalian Genome, 2018, v. 29, n. 11/12, p. 777, doi. 10.1007/s00335-018-9781-4
- By:
- Publication type:
- Article
7
Thymocyte self-renewal and oncogenic risk in immunodeficient mouse models: relevance for human gene therapy clinical trials targeting haematopoietic stem cell populations?
- Published in:
- Mammalian Genome, 2018, v. 29, n. 11/12, p. 771, doi. 10.1007/s00335-018-9780-5
- By:
- Publication type:
- Article
8
B cells and antibody production in melanoma.
- Published in:
- Mammalian Genome, 2018, v. 29, n. 11/12, p. 790, doi. 10.1007/s00335-018-9778-z
- By:
- Publication type:
- Article
9
Radiation, inflammation and the immune response in cancer.
- Published in:
- Mammalian Genome, 2018, v. 29, n. 11/12, p. 843, doi. 10.1007/s00335-018-9777-0
- By:
- Publication type:
- Article
10
Identifying neoantigens for use in immunotherapy.
- Published in:
- Mammalian Genome, 2018, v. 29, n. 11/12, p. 714, doi. 10.1007/s00335-018-9771-6
- By:
- Publication type:
- Article
11
Interaction of PVR/PVRL2 with TIGIT/DNAM-1 as a novel immune checkpoint axis and therapeutic target in cancer.
- Published in:
- Mammalian Genome, 2018, v. 29, n. 11/12, p. 694, doi. 10.1007/s00335-018-9770-7
- By:
- Publication type:
- Article
12
The role of proteomics in the age of immunotherapies.
- Published in:
- Mammalian Genome, 2018, v. 29, n. 11/12, p. 757, doi. 10.1007/s00335-018-9763-6
- By:
- Publication type:
- Article
13
The intertwined fates of inflammation and coagulation in glioma.
- Published in:
- Mammalian Genome, 2018, v. 29, n. 11/12, p. 806, doi. 10.1007/s00335-018-9761-8
- By:
- Publication type:
- Article
14
A mouse model of the Δ133p53 isoform: roles in cancer progression and inflammation.
- Published in:
- Mammalian Genome, 2018, v. 29, n. 11/12, p. 831, doi. 10.1007/s00335-018-9758-3
- By:
- Publication type:
- Article
15
Immune cell profiling in the age of immune checkpoint inhibitors: implications for biomarker discovery and understanding of resistance mechanisms.
- Published in:
- Mammalian Genome, 2018, v. 29, n. 11/12, p. 866, doi. 10.1007/s00335-018-9757-4
- By:
- Publication type:
- Article
16
Manipulating the tumor microenvironment by adoptive cell transfer of CAR T-cells.
- Published in:
- Mammalian Genome, 2018, v. 29, n. 11/12, p. 739, doi. 10.1007/s00335-018-9756-5
- By:
- Publication type:
- Article